Research at Children's
About Us
Our Research
Faculty
By Research Center
By Name
Education
Clinical Trials
Latest News
Careers
 
 
Email this page Email This Page
Print this page Print This Page
 

  Join Us On:
  Follow Children's on Facebook  Facebook
  Follow Children's on Twitter  Twitter
  Watch Children's on YouTube  YouTube
 
 
     
 

Kimberly Chapman, MD, PhD - Center for Genetic Medicine Research - Children's Research Institute - Children's National Medical Center Kimberly Chapman, MD, PhD

Kimberly Chapman Children's National Medical Center
Principal Investigator, Children's Research Institute (CRI), Center for Genetic Medicine Research (CGMR)

George Washington University


Contact Information
Children's National Medical Center
Center for Genetic Medicine Research (CGMR)
111 Michigan Avenue, NW
Washington, DC 20010-2970

202-476-5000
kchapman@childrensnational.org

Education & Training
Institution & Location Degree Year(s) Field of Study
St. Louis University,
St. Louis, MO
BS
1995
Chemistry
St. Louis University,
St. Louis, MO
BA
1995 Biology
University of Nebraska, Omaha, NE
PhD
2000
Biochemistry/Molecular Biology
University of Nebraska Medical Center,
Omaha, NE
MD
2002

University of Pittsburgh, Pittsburgh, PA
Intern
2002 -
2003
Medicine/Pediatrics
University of Pittsburgh, Pittsburgh, PA Resident
2003 -
2006
Medicine/Pediatrics
Children's Hospital of Philadelphia,
Philadelphia, PA
Fellow
2006 -
2010
Clinical Genetics/Clinical Biochemical Genetics

Research Interests
Dr. Chapman studies the response to stress initiated by a block at metabolic enzymes that cause inborn errors of metabolism (IEM). People with IEM are exposed to exogenous stress (low calories, high protein diet, anxiety, cold weather, illness) and endogenous stress (the blockade at a particular enzyme) and each of their cells responds with a cascade of events to maintain equilibrium and promote survival. Dr. Chapman studies whether these responses cause secondary pathophysiology leading to the differing phenotypes seen in patients.

Dr. Chapman's lab has examined cell lines from patients with IEM and has identified the expression responses in cell lines from patients with Propionic Acidemia. Using a model of increasing cellular stress to further perturb these responses, the implications of a biochemical enzyme block is compared to the responses of “presumably healthy” controls.  At present Dr. Chapman is identifying the individual components of responses and their interactions with each other using computational methods, genetics (using individual genetic variation in response regulation as a tool) and standard molecular biology techniques.

Clinical Interests 
Click here for more information about this doctor's clinical practice, including how to make an appointment.

Publications
View a partial list of publications for Kimberly Chapman through the National Library of Medicine's PubMed online database.


Back to Top
 


   
Children's National Medical Center |
111 Michigan Avenue, NW Washington, DC 20010 | 202-476-5000 | © 2013 & Privacy Statement